Abstract
Get full access to this article
View all access options for this article.
References
1.
Poser
CM.
Clinical diagnostic criteria in epidemiological studies of multiple sclerosis . Ann New York Acad Sci 1965 ; 122 (1 ): 506 –519 .
2.
Lublin
FD
Reingold
SC
Cohen
JA
, et al . Defining the clinical course of multiple sclerosis: The 2013 revisions . Neurology 2014 ; 83 (3 ): 278 –286 .
3.
Coetzee
T
Thompson
AJ.
Unified understanding of MS disease is required for drug development . Nat Rev Neurol 2018 ; 391 : 1622 –1636 .
4.
Ramanujam
R
Zhu
F
Fink
, et al . Accurate classification of secondary progression in multiple sclerosis using decision tree , https://www.medrxiv.org/content/10.1101/2020.07.09.20149674v1
5.
Cruz Rivera
S
Liu
X
Chan
AW
, et al . Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI extension . Lancet Digital Health 2020 ; 2 (10 ): e549–e560.